Zhiquan Hu
Zhiquan Hu
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Gemcitabine Plus Trastuzumab Rezetecan in HER2-positive UTUC | renal pelvis/ureter urothelial carcinoma | Recruiting | Phase 2 | 2026-08-03 | NCT07741448 | |
| Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC | MIBC | Recruiting | Phase 3 | 2026-07-09 | NCT07693959 |